Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?

Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?

Source: 
Motley Fool
snippet: 
  • Moderna awaits FDA decisions on full approval for its COVID-19 vaccine and for booster doses.
  • Boosters will make a bigger financial impact over the long run.
  • Full FDA approval is a must-have for Moderna but likely won't impact vaccine sales very much.